An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and June 2022. The service provided comprehensive patient-specific ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...

Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.

JonesTrading analyst Justin Walsh has reiterated their bullish stance on RAPP stock, giving a Buy rating on November 7. Justin Walsh’s ...

The study, published today in JAMA Network Open, tracked patients hospitalized for hip fractures in Victoria, Australia from March 2013 through June 2018, who had used gabapentinoids before the injury ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

The resulting paper, “Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: ...

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...